Skip to main content

Table 2 Comparison of the incidence of gut dysbiosis in the patients from the three groups

From: The prophylactic effects of BIFICO on the antibiotic-induced gut dysbiosis and gut microbiota

  Control group (n = 64) Regular group (n = 67) Double-dosage group (n = 65) P-value
Within 7 days
 Incidence of gut dysbiosis (%) 21.88 14.93 6.15** 0.038*
Days 8–14
 Incidence of gut dysbiosis (%) 25.00 14.93 4.62** 0.005**
  1. * P < 0.05, **P < 0.01 compared to Control group